Microvascular leak — protein and fluid extravasation
Vasculitis in multiple organ systems simultaneously
Organ-specific consequences
CNS — meningoencephalitis from cerebral vasculitis
Lung — non-cardiogenic pulmonary edema, ARDS
Kidney — renal tubular injury and acute kidney injury
Skin — petechial rash from microvascular hemorrhage
Myocardium — myocarditis from cardiac endothelial involvement
Coagulation — thrombocytopenia from platelet consumption and endothelial damage
Therapeutic Considerations
Mechanism of doxycycline efficacy
Mode of action
Inhibits ribosomal 30S subunit — bacteriostatic
Penetrates host cells to reach intracellular Rickettsia
Achieves high intracellular concentrations
Clinical response benchmark
Fever resolves within 24–48 hours of doxycycline if started in first 4–5 days
Failure to defervesce within 48 hours should prompt diagnostic reassessment
Evidence basis for treatment decisions
MMWR 2016 CDC guidelines (Biggs et al.)
Doxycycline first-line for all ages, all presentations
Empiric treatment before confirmatory testing
Wilderness Medical Society guidelines 2021
Tick bite prevention and management recommendations
No prophylactic antibiotics after asymptomatic tick bite
IDSA/ASM microbiology laboratory guide 2024
IFA serology gold standard for confirmation
PCR as adjunct during acute febrile phase
Natural history without treatment
Untreated outcome trajectory
Initial fever and myalgia evolving over 2–4 days
Rash appears days 2–4 after fever
Petechiae signify advanced microvascular injury by days 5–6
Multi-organ failure and death risk sharply rises after day 5 without treatment
Long-term sequelae after severe disease
Neurologic complications
Cognitive impairment
Sensorineural hearing loss
Paraparesis or monoparesis
Vascular complications
Limb amputation after gangrene in fulminant cases
No reliable immunity after infection — reinfection possible
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for Rocky Mountain Spotted Fever
Your diagnosis and treatment
You have been diagnosed with Rocky Mountain Spotted Fever, a serious infection caused by bacteria transmitted by tick bites
You have been prescribed doxycycline to treat this infection
Take doxycycline exactly as prescribed — complete the full course even if you feel better
Take doxycycline with a full glass of water and remain upright for 30 minutes to reduce stomach upset
Avoid antacids, calcium supplements, iron, and dairy within 2 hours of doxycycline — these reduce absorption
Expected recovery
Fever should begin to improve within 24–48 hours of starting doxycycline
If fever does not improve within 48 hours, return to the emergency department
Fatigue and muscle aches may persist for several days after fever resolves
Follow-up required
Return to your doctor or this emergency department within 24–48 hours
This is required to ensure you are improving on treatment
Return to the emergency department immediately if
Fever is not improving or is worsening after 48 hours on antibiotics
New rash appears or existing rash spreads, changes color, or develops purple/red spots (petechiae)
Confusion, difficulty thinking, unusual behavior, or seizures
Severe headache or neck stiffness
Shortness of breath or chest pain
You are unable to keep your antibiotic down due to vomiting
Decreased urination or swelling of face, hands, or feet
Any rapid or dramatic worsening of symptoms
Tick prevention going forward
Use DEET-based insect repellent on exposed skin and permethrin-treated clothing in tick habitats
Perform daily tick checks on yourself, children, and pets after outdoor activities
Remove ticks promptly with fine-tipped tweezers — grasp near skin surface and pull upward steadily
You are not immune after this infection — you can get Rocky Mountain Spotted Fever again
References
Guidelines and key sources
Primary guideline reference
Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and Management of Tickborne Rickettsial Diseases. MMWR Recomm Rep. 2016
CDC primary guideline for RMSF and other spotted fever rickettsioses
Doxycycline first-line for all ages including children under 8 years
Empiric treatment without awaiting confirmatory results
Gottlieb M, Long B, Koyfman A. Evaluation and Management of RMSF in the Emergency Department. J Emerg Med. 2018
Emergency department focused review
Clinical pearls for early recognition and treatment
Ho BM, Davis HE, Forrester JD, et al. Wilderness Medical Society Clinical Practice Guidelines for Tick-Borne Illness. Wilderness Environ Med. 2021
Tick prevention and management recommendations
No prophylactic antibiotics after asymptomatic tick bite
Miller JM, Binnicker MJ, Campbell S, et al. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update. IDSA/ASM. Clin Infect Dis. 2024
IFA serology gold standard — acute and convalescent paired samples
PCR utility during acute febrile phase
Bejarano JIC, Gonzalez EAL, et al. Epidemiologic Characterization and Risk Factors of RMSF in Children in Northeastern Mexico 2018–2024. Arch Med Res. 2026
Pediatric RMSF epidemiology and risk factor analysis
Travel medicine reference for rickettsial diseases
Clinical and epidemiologic summary
Pace EJ, O'Reilly M. Tickborne Diseases: Diagnosis and Management. Am Fam Physician. 2020
Primary care and emergency medicine overview of tick-borne illness spectrum
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.